Abstract
To assess the urinary markers of podocytic (nephrin) and tubulointerstitial damage (NGAL, KIM-1, albuminuria) levels in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) stages 3 and 4 and to evaluate their relationship with bleedings during rivaroxaban treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
